Photo Booth for the Pharmaceutical Industry — Audit-Reviewed Lead Generation

Pharma events, medical congresses and physician symposia are subject to the strictest compliance guidelines in the industry. Generic event technology fails here on missing audit trails and undocumented data processing. UpReach gives medical marketing a privacy-first architecture: AI processing is GDPR-compliant. Configurable, multi-stage opt-in processes meet the requirements of the FSA code for healthcare-professional leads. The system turns stand visitors into usable B2B records — legally secured and in the flawless corporate design of the pharma brand.

More than 200 B2B brands from across Europe trust UpReach — from agencies to enterprise corporations.

The technological lever for medical affairs

GDPR-compliant data processing (privacy first)

AI processing of backgrounds and face enhancement is GDPR-compliant, with consent captured at the terminal. Personal image data is deleted immediately after the image is produced. Deletion after rendering is available on request for full evidence. An on-device edge/offline mode is available on request for maximally sensitive deployments.

FSA-compliant consent flows

Every lead is provable: the system supports multi-stage consent checkboxes that guide HCPs to state their specialism and give differentiated consent before data is handed to Salesforce or Veeva. The export carries every record with a cryptographically secured opt-in timestamp.

100% white-label brand identity

Pharma stands tolerate no third-party logos. The entire user interface — from standby screen to GDPR input mask — is configured centrally to the pharma brand's guidelines. Campaign changes happen via cloud push with no technician at the stand.

Evaluated scenarios in the pharma sector

Professional background removal and face enhancement, GDPR-compliant. For pharma events that means AI-grade business portraits for LinkedIn, with biometric processing handled GDPR-compliantly and biometric raw data deleted after rendering. Compliance documentation for procurement teams on request.

A product line manufactured to our own specification (CE, ISO 9001) — built for continuous operation on congress floors. A compact footprint for tight trade-show stands. Fully offline-capable for unreliable congress Wi-Fi. The system buffers leads encrypted and syncs once the network returns.

Why UpReach for the pharmaceutical industry

The UpReach software is configurable for pharma compliance workflows: FSA-compliant opt-in text, granular consents for different processing purposes (photo consent, sales follow-up, newsletter), full audit trails. The consent logic is defined by the pharma group's legal team and built directly into the software.

Professional background removal and face enhancement, GDPR-compliant. For pharma events that means AI-grade business portraits for LinkedIn, with biometric processing handled GDPR-compliantly and biometric raw data deleted after rendering. Compliance documentation for procurement teams on request.

A product line manufactured to our own specification (CE, ISO 9001) — built for continuous operation on congress floors. A compact footprint for tight trade-show stands. Fully offline-capable for unreliable congress Wi-Fi. The system buffers leads encrypted and syncs once the network returns.

For medical congresses and B2B lead generation, the Pro V1 (from €6,990 net) is the standard: durable, all compliance features, ISO 9001. For mobile roadshows between several congress locations, the Compact (from €4,990 net) suits with its compact footprint and full offline capability. For repeated deployments at several congresses a year, purchase is more economical than rental. All prices excl. VAT. The software ecosystem is included for 12 months in the purchase price (annual contract thereafter); AI modules are credit-based/modular.

Certifiable data structure for the healthcare market

Audit trail for the data protection officer

For pharma groups, the audit trail is a mandatory requirement: who captured which data, when, for what purpose, with what consent? The UpReach system documents every step: cryptographically secured timestamps for every opt-in, a full consent log, deletion evidence after the defined deletion cycle. This documentation is handed to the group's data protection officer before the event — no surprises in the subsequent compliance review.

FSA-compliant HCP lead capture

The FSA code (the German pharmaceutical industry's voluntary self-regulation) defines strict requirements for capturing healthcare-professional data. UpReach implements multi-stage consent flows directly in the terminal software: separating photo consent from sales follow-up, explicit specialism input, differentiated opt-in categories. Only when the HCP actively confirms all relevant consents does the system generate the lead. The export after the event contains every record with its full consent structure — directly importable into Veeva or Salesforce Health Cloud.

CRM integration for the pharma sales pipeline

The value of an HCP lead in pharma field sales is well above that of a standard B2B contact. The UpReach system exports leads via REST API straight into Salesforce, Veeva or HubSpot: name, email, specialism, consent timestamp, consent type per processing purpose. Marketing receives a segmented record instead of a homogeneous raw list. For GDPR-compliant follow-up, every contact is linked to its individual consent history — no legal risk from messy address lists.

Recommended UpReach products for the pharmaceutical industry

AI Photo Booth — For medical congresses and symposia — compliance-reviewed, GDPR-compliant, FSA-configurable.

iPad Photo Booth — For smaller advisory boards and internal events with a minimal footprint.

Roaming Photo Booth — For large congress floors where promo staff approach physicians actively.

Frequently asked questions from the pharmaceutical industry

Does the system pass the compliance team's review?

Yes. The system is built on privacy-by-design principles. UpReach provides the compliance team with technical documentation up front: full data flow, DPA, server-location evidence, biometric architecture, deletion workflow. Data packets are transmitted SSL-encrypted only. The system is classified as a low-risk application under the EU AI Act — GDPR-compliant processing of biometric data, with no third-country transfer risk.

Can the lead masks be adapted to the FSA code?

That is the focus with pharma clients. Your legal team defines the text blocks and checkboxes — separating photo consent from sales follow-up, specialism input, differentiated processing purposes. Only when the HCP actively confirms all relevant consents does the terminal generate the lead. The export after the congress contains every record with the exact consent timestamp.

Does the system need permanent internet access at the congress stand?

No. Congress Wi-Fi is notoriously unreliable. The terminal handles all AI functions and the GDPR input fully offline on the device. Leads are buffered encrypted on the internal drive. Once the network stabilises, or after the event ends, the dashboard syncs the queue automatically.

How do we budget pharma-congress setups?

The Pro V1 (from €6,990 net) is the standard for medical congresses. For roadshows across several congress locations, the Compact (from €4,990 net) suits. With several congresses a year, purchase pays off versus rental from the second deployment. The software ecosystem is included for 12 months in the purchase price; AI modules credit-based/modular. All prices excl. VAT.

What documentation do we receive for internal compliance sign-off?

On request, UpReach provides full compliance documentation: technical data flow, biometric architecture, DPA (data processing agreement), server-location evidence, deletion-workflow description. This documentation is designed as the basis for internal IT and data protection sign-off — including for procurement teams with strict vendor-assessment processes.

Does the system meet the EU AI Act for biometric image processing?

Yes. AI processing is GDPR-compliant; biometric raw data is deleted after rendering. After the image is produced, the image data is deleted immediately. This architecture is classified as a low-risk application under the EU AI Act. For pharma groups that factor the EU AI Act into their vendor due diligence, the full compliance documentation is available on request.

Still have questions?

Contact our team

Lead marketing with no compliance risk at the congress

Capture HCP contacts within a legally secured frame — the IT documentation is ready for compliance sign-off.